As enthusiastic business leaders adopt the latest AI gizmos to cut costs and boost efficiency, employees aren't fully on board.

The AI sector has exploded since 2022, largely based on the growth of Altman’s company and its flagship product, ChatGPT.

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...